Back

Risk of adverse events in takotsubo syndrome compared to heart failure: observations from a global federated network

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Prognosis and heart failure Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Enrico Tartaglia

Modena Polyclinic Modena University Hospital, Modena (Italy)

6 More presentations in this session

Presentation thumbnail
Cardiorenal outcomes and all-cause mortality in patients with comorbid heart failure and chronic kidney disease across three countries (The CaRe Study)
Associate Professor G. Savarese (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Short-term exposure to low and high temperatures and mortality in heart failure patients: a nationwide study in Sweden
Professor S. Agewall (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Prognostic impact of the INTERMACS class and advanced HF according to 4 HFA-ESC 2018 criteria: Insights From the HELP-HF Registry
Doctor M. De Carli (Rozzano, IT)
Abstract Slides Video
Presentation thumbnail
Lipid-lowering therapy is associated with lower mortality in heart failure patients: Insights from Swedish national registries data from 2006 to 2022
Doctor A. Berg (Gothenburg, SE)
Abstract Slides Video
Presentation thumbnail
Right ventricular-pulmonary artery coupling in acute heart failure: prognostic significance and implications for intensive care management
Miss A. Caputo (Rome, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Prognosis and heart failure

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Clinical course of atrial fibrillation patients with and without history of takotsubo syndrome: a propensity matched analysis from the GEIST and ATHERO-AF registries
thumbnail
Congress Presentation
Factors for heart failure at discharge in takotsubo syndrome
thumbnail
Congress Presentation
Cardiovascular and non-cardiovascular prescribing and mortality after takotsubo

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources